TOXYS Revenue and Competitors

Leiden,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • TOXYS's estimated annual revenue is currently $6M per year.(i)
  • TOXYS's estimated revenue per employee is $155,000

Employee Data

  • TOXYS has 39 Employees.(i)
  • TOXYS grew their employee count by 3% last year.

TOXYS's People

NameTitleEmail/Phone
1
Chief Scientific OfficerReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Scientific DirectorReveal Email/Phone
4
Study DirectorReveal Email/Phone
5
Office ManagerReveal Email/Phone
6
Postdoctoral Researcher - ReproTrackerReveal Email/Phone
7
Study investigatorReveal Email/Phone
8
Research TechnicianReveal Email/Phone
9
PresidentReveal Email/Phone
10
Laboratory TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is TOXYS?

Toxys is a Dutch biotech company and service laboratory that offers a broad spectrum of innovative in vitro solutions with expertise in genotoxicity, developmental and mechanistic toxicity screening. We aim to bring information to our customers that is essential to make decisions on which compounds to progress in drug/product development. We work together with customers from different industries ranging from pharmaceutical companies to chemical and consumer-goods companies and from large size companies to small start-ups. We are devoted to offer our unique assays such as ToxTracker®, ToxTrackerPlus® and Reprotracker® together with the conventional genotoxicity assays as tailored service to our customers, combined with the responsiveness and flexibility found only in dedicated companies.

keywords:N/A

N/A

Total Funding

39

Number of Employees

$6M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TOXYS News

2022-03-22 - Toxys Opens NY Sales Office And Facility In Maryland

Toxys BV, a Dutch biotech company that offers a broad spectrum of in vitro toxicology solutions for the safety assessment of novel medicines...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.2M462%N/A
#2
$13.4M5510%N/A
#3
$9.5M613%N/A
#4
$12.9M6548%N/A
#5
$10.1M6535%N/A